Search results
Drug reprograms immune responses to target glioblastoma
Medical Xpress· 7 hours agoInvestigators from Northwestern University Feinberg School of Medicine and The University of Texas...
Reinvigorating exhausted immune cells reveals potential therapy target for cancer
Medical Xpress· 5 days agoIn working to understand the ecosystem's role in cancer risk, development and treatment, researchers at The Jackson Laboratory have not only identified how two immune cells work together to ...
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan
Science Daily· 7 days agoScientists at St. Jude Children's Research Hospital and the University of Minnesota investigated the unique 'epigenetic clock' of T-cell aging, demonstrating ...
Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases
Clinical Trials Arena via Yahoo Finance· 12 hours agoUS-based biopharmaceutical company Mozart Therapeutics has dosed the first subjects in its Phase...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks· 16 hours agoFree Report) reported updated results from a cohort of an ongoing phase I/II study evaluating its lead clinical candidate MB-106 in patients with Waldenstrom macroglobulinemia (WM), a rare form ...
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan
Medical Xpress· 6 days agoScientists at St. Jude Children's Research Hospital and the University of Minnesota investigated the unique 'epigenetic clock' of T cell aging, demonstrating ...
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Pharmaceutical Technology via Yahoo Finance· 2 days agoBased on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 1 day agoOdronextamab is a novel bispecific T-cell engager (BiTE) that targets CD20 on B cells and CD3 on T...
EU regulator mandates label updates on CAR-T cancer therapies
WHTC 1450 Holland· 4 days ago(Reuters) - The European health regulator said on Friday product information for a class of cancer...
How Glowing Dye That Clings to Cancer Cells Gives Doctors ‘second pair of eyes’
GoodNewsNetwork· 4 days agoDeveloped for use in the removal of prostate cancer, the dye could be adapted to other cancers but...